Psyence Biomedical Ltd. PBM
5.56
(0.30)
(5.12%)
as of 25 Sep
- Market cap
- $22.4M
- P/E
- 0.2×
Follow PBM
| Sep '25 | Mar '25 | Sep '24 | Mar '24 | Older periods | |
|---|---|---|---|---|---|
| (23.52%) | 0.00% | (189.96%) | 0.00% |
+8 more TTM periods Free account |
|
| (15.37%) | 0.00% | (2.74%) | 0.00% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(14.70%) | 0.00% | 20.36% | 0.00% | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(34.08) | — | (1,125.07) | 0.00 | |
Free Cash Flow |
(8.08) | — | (6.30) | (5.33) | |
Piotroski F-Score |
1.00 | — | 1.00 | — | |
| Other line items | |||||
Cash ROIC |
(42.37%) | 0.00% | (891.15%) | 52.25% | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | — | 0.00 | — | |
Selling, General and Administrative Expense of Revenue |
0.00% | — | 0.00% | — | |
Operating CF/Net income |
8.21 | — | 24.66 | 0.00 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | — | 0.00 | — | |
Operating CF per Share |
(34.08) | — | (1,125.07) | 0.00 | |
Capex per Share |
0.00 | — | 0.00 | — | |
Net Profit Margin |
0.00% | — | 0.00% | — |
Columns are period end dates